September 11, 2025 NAION MDL Sought (by Lilly) Eli Lilly has filed a motion to centralize all federal lawsuits alleging vision loss from GLP-1 receptor agonist drugs, specifically claims involving non-arteritic anterior ischemic optic neuropathy (NAION)
However, the silver lining is that, with the knowledge we have today about alcohol metabolism, we can even act preemptively
CJC-1295 No DAC, as a tool for restoring GHRH receptor stimulation and augmenting pulsatile GH output, has been studied in preclinical models of somatopause-associated metabolic change
Common adverse effects: Nausea Vomiting Diarrhoea Constipation Reduced appetite Dose escalation increased gastrointestinal side effects
And then the way you look, that's the side effect, believe it or not
The improvements in male patients desire, erectile function, and sexual satisfaction corroborate the mechanism we expect from PT-141s central action